<DOC>
	<DOC>NCT00366964</DOC>
	<brief_summary>This study is being done to compare the efficacy of an FDA cleared laser device with other similar systems in the market for the treatment of leg veins and hair removal in patients with darker skin type.</brief_summary>
	<brief_title>The Efficacy Of The Wavelight Mydon Laser for Hair Removal And Treatment of Leg Veins</brief_title>
	<detailed_description>The specific aim of the study is to determine the efficacy of this FDA approved laser for hair removal and treatment of leg veins in female patients having darker skin types (Fitzpatrick Skin type III-VI) and compare it with the efficacy of other similar commercial units available in the U.S.</detailed_description>
	<criteria>1. Female patients of Asian and darker skin type greater than or equal to 18 years of age. 2. Ability to give informed consent. 1. Pregnancy. 2. Taking medications that are photosensitizing. 3. History of skin disease in the area to be treated over the last 6 months. 4. Ongoing cutaneous lupus erythematosus, morphea, alopecia areata, or severe folliculitis. 5. History of keloidal or hypertrophic scarring. 6. Have inadequate hair growth in the test area of axilla. 7. Have unrealistic expectations of the treatment. 8. Coexisting severe emotional, medical or surgical illness leading to the inability to meet the followup requirements.</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>